Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;2(3):385-391.
doi: 10.3892/etm.2011.234. Epub 2011 Mar 21.

Detection of circulating tumor cells: Clinical relevance of a novel metastatic tumor marker

Affiliations

Detection of circulating tumor cells: Clinical relevance of a novel metastatic tumor marker

Chuanli Ren et al. Exp Ther Med. 2011 May.

Abstract

Most cancer-related deaths are caused by the hematogenous spread of cancer cells to distant organs and their subsequent metastasis. During the early stages of the metastatic cascade, cancer cells disseminate from the primary site via the lymphatic vessels and/or by hematogenous routes. Circulating tumor cells (CTCs), cancer cells that have disseminated into the systemic circulation, may be a predictor of poor prognosis in several carcinomas. An understanding of the molecular mechanisms involved in the blood-borne dissemination of cancer cells may help to clarify the process of metastasis and provide a powerful and non-invasive approach for anticancer treatments that are tailored to individual patients.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The process of CTC metastasis. Cancer cells with localized invasion require epithelial mesenchymal transition (EMT), by which adherent cancer cells achieve the ability to migrate, as well as with the loss of integrity of the basement membrane (BM) and the extracellular matrix (ECM). The process permits some metastatic cancer cells to intravasate into the blood. CTCs interact with the microenvironment in the circulation. Finally, only a small proportion of CTCs with the ability to metastasize, or those with traits similar to those of cancer stem cells, are thought to extravasate to distal organs and develop macrometastases. Genetic and molecular analysis of these rare cells may provide a novel tool for evaluating their biological and clinical relevance.
Figure 2.
Figure 2.
Enrichment and identification of CTCs. CTCs were stained with (A) anti-cytokeratin 8/18/19-Alexa 488-positive, (B) anti-CD45-Alexa 594-negative, (C) 4,6-diamidino-2-phenylindole (DAPI)-positive antibodies. (D) Merged image of A, B and C; (E and G) CTCs re-stained with Hematoxylin and Eosin (H&E). (F and H) CTCs hybridized with DNA probes targeting specific chromosome 8 (green) and chromosome 20 (red), showing polysomy of chromosomes 8 and 20. Original magnification, ×100. Scale bar, 10 μm.

Similar articles

Cited by

References

    1. Maheswaran S, Haber DA. Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev. 2010;20:96–99. - PMC - PubMed
    1. Pantel K, Alix-Panabieres C, Riethdorf S. Cancer micro-metastases. Nat Rev Clin Oncol. 2009;6:339–351. - PubMed
    1. Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008;8:329–340. - PubMed
    1. Ashworth A. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J. 1869;14:146–149.
    1. Mocellin S, Keilholz U, Rossi CR, Nitti D. Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med. 2006;12:130–139. - PubMed

LinkOut - more resources